Prosecution Insights
Prosecution Insights
25 pending office actions • 14 art units • 23 examiners • 0 of 25 (0%) have an AI response strategy ready
Based on the USPTO statutory response window for each pending office action. 18 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 18 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 4 (16%) |
| §102 only | 1 (4%) |
| §112 only | 1 (4%) |
| Double-patenting only | 1 (4%) |
| Double-patenting + other | 2 (8%) |
| Multi-statute (no §101) | 16 (64%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LEVIN, JOEL D | 2 | 56.4% | +46.5% |
| TRAN, KHOA NHAT | 2 | 42.0% | +58.8% |
| EBBINGHAUS, BRIANA NOEL | 1 | 62.9% | +61.6% |
| CHEN, CATHERYNE | 1 | 37.5% | +18.2% |
| BELYAVSKYI, MICHAIL A | 1 | 64.1% | +27.7% |
| LEONARD, ARTHUR S | 1 | 50.9% | +50.5% |
| FOX, ALLISON M | 1 | 71.4% | +35.3% |
| PALENIK, JEFFREY T | 1 | 53.8% | +26.8% |
| OGUNBIYI, OLUWATOSIN A | 1 | 63.7% | +41.5% |
| ZHU, JIANJIAN | 1 | 61.0% | +83.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17310051 | FIBROBLASTS AND MICROVESICLES THEREOF FOR REDUCTION OF TOXICITY ASSOCIATED WITH CANCER IMMUNOTHERAPY | DHAR, MATASHA | 86d overdue |
| 17052859 | PAIN-REDUCING EFFECTS OF FIBROBLASTS AND TREATMENT OF PAIN | TRAN, KHOA NHAT | 73d overdue |
| 17595112 | FIBROBLAST GENERATED PATIENT-SPECIFIC VACCINES | CHASE, CAROL ANN | 43d overdue |
| 17755834 | FIBROBLAST THERAPY FOR INFLAMMATORY BOWEL DISEASE | MOSS, NATALIE M | 32d overdue |
| 17310007 | FIBROBLAST REGENERATIVE CELLS | TRAN, KHOA NHAT | 25d overdue |
| 18486731 | GENE THERAPY FOR THE REGENERATION OF CHONDROCYTES OR CARTILAGE TYPE CELLS | LEONARD, ARTHUR S | 18d overdue |
| 18658989 | MEANS AND METHODS OF PREVENTING OR REVERSING AGING | EBBINGHAUS, BRIANA NOEL | 10d overdue |
| 17309178 | TREATMENT OF CEREBRAL HYPOXIA INCLUDING STROKE, CHRONIC TRAUMATIC ENCEPHALOPATHY, AND TRAUMATIC BRAIN INJURY | XU, QING | 3d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17052859 | PAIN-REDUCING EFFECTS OF FIBROBLASTS AND TREATMENT OF PAIN | TRAN, KHOA NHAT | 73d overdue |
| 17310007 | FIBROBLAST REGENERATIVE CELLS | TRAN, KHOA NHAT | 25d overdue |
| 18486731 | GENE THERAPY FOR THE REGENERATION OF CHONDROCYTES OR CARTILAGE TYPE CELLS | LEONARD, ARTHUR S | 18d overdue |
| 18658989 | MEANS AND METHODS OF PREVENTING OR REVERSING AGING | EBBINGHAUS, BRIANA NOEL | 10d overdue |
| 18042323 | DENTAL AND PERIODONTAL APPLICATION OF FIBROBLASTS | LEVIN, JOEL D | 34d |
| 17999583 | FIBROBLAST THERAPY FOR PREVENTION AND REVERSION OF ANEURYSMS | FOX, ALLISON M | 42d |
| 17996033 | TREATMENT OF ERECTILE DYSFUNCTION BY FIBROBLAST ADMINISTRATION | ZHU, JIANJIAN | 54d |
| 17996109 | GENE MODIFIED FIBROBLASTS FOR THERAPEUTIC APPLICATIONS | OGUNBIYI, OLUWATOSIN A | 56d |
| Art Unit | Apps |
|---|---|
| 1632 | 5 |
| 1631 | 5 |
| 1633 | 3 |
| 1655 | 1 |
| 1615 | 1 |
| 1645 | 1 |
| 1682 | 1 |
| 1644 | 1 |
| 1619 | 1 |
| 1653 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18658989 | MEANS AND METHODS OF PREVENTING OR REVERSING AGING | EBBINGHAUS, BRIANA NOEL | 1632 | §102§103§112 | Non-Final OA | 10d overdue | Pending | May 09, 2024 |
| 18615328 | STIMULATION OF ANGIOGENESIS BY FIBROBLAST DERIVED EXOSOMES | CHEN, CATHERYNE | 1655 | DPOther | Non-Final OA | 70d | Pending | Mar 25, 2024 |
| 18603451 | AUGMENTATION OF FIBROBLAST REGENERATIVE ACTIVITY | BELYAVSKYI, MICHAIL A | — | DP | Non-Final OA | — | Pending | Mar 13, 2024 |
| 18486731 | GENE THERAPY FOR THE REGENERATION OF CHONDROCYTES OR CARTILAGE TYPE CELLS | LEONARD, ARTHUR S | 1631 | §102§112Other | Final Rejection | 18d overdue | Pending | Oct 13, 2023 |
| 18042323 | DENTAL AND PERIODONTAL APPLICATION OF FIBROBLASTS | LEVIN, JOEL D | 1633 | §102§103 | Non-Final OA | 34d | Pending | Feb 21, 2023 |
| 17999583 | FIBROBLAST THERAPY FOR PREVENTION AND REVERSION OF ANEURYSMS | FOX, ALLISON M | 1633 | §102§103Other | Non-Final OA | 42d | Pending | Nov 22, 2022 |
| 17997674 | REDUCTION OF CYTOKINE STORM AND PATHOLOGICAL INFLAMMATION INCLUDING CAUSED BY CORONAVIRUS USING SPHAGNUM AND EXTRACTS THEREOF | PALENIK, JEFFREY T | 1615 | §102§103 | Final Rejection | 72d | Pending | Nov 01, 2022 |
| 17996109 | GENE MODIFIED FIBROBLASTS FOR THERAPEUTIC APPLICATIONS | OGUNBIYI, OLUWATOSIN A | 1645 | §103 | Final Rejection | 56d | Pending | Oct 13, 2022 |
| 17996033 | TREATMENT OF ERECTILE DYSFUNCTION BY FIBROBLAST ADMINISTRATION | ZHU, JIANJIAN | 1631 | §103§112Other | Non-Final OA | 54d | Pending | Oct 12, 2022 |
| 17995609 | IMMUNOTHERAPEUTIC METHODS AND COMPOSITIONS FOR TARGETING CANCER FIBROBLASTS | HUMPHRIES, NICHOLAS ADAM | 1631 | §103DPOther | Final Rejection | — | Pending | Oct 06, 2022 |
| 17905197 | GENERATION OF AUTOIMMUNE INHIBITORY T CELLS BY FIBROBLAST MEDIATED EDUCATION | MIANO, JOSEPH PAUL | 1631 | §103Other | Non-Final OA | 27d | Pending | Aug 29, 2022 |
| 17904180 | TELOMERE LENGTH MODULATION USING FIBROBLASTS | SHEN, WU CHENG WINSTON | 1682 | §102§103§112 | Final Rejection | — | Pending | Aug 12, 2022 |
| 17757383 | SUPPRESSION OF INTERLEUKIN-17 PRODUCTION AND INHIBITION OF TH17 CELL GENERATION BY FIBROBLASTS AND PRODUCTS THEREOF | JOHANSEN, PETER N. | 1644 | §112 | Final Rejection | — | Pending | Jun 15, 2022 |
| 17757314 | AUGMENTATION OF FIBROBLAST MEDIATED REGENERATION OF INTRAVERTEBRAL DISCS | MITCHELL, EDWIN COLEMAN | 1619 | §103 | Non-Final OA | — | Pending | Jun 14, 2022 |
| 17755834 | FIBROBLAST THERAPY FOR INFLAMMATORY BOWEL DISEASE | MOSS, NATALIE M | 1653 | §102§103 | Final Rejection | 32d overdue | Pending | May 10, 2022 |
| 17755278 | INTRATUMORAL ADMINISTRATION OF IMMUNE CELLULAR THERAPEUTICS | CHATTIN, AMY MARIE | 1643 | §102§103§112 | Final Rejection | 72d | Pending | Apr 26, 2022 |
| 17754106 | CANNABIDIOL ADJUVANT THERAPY FOR TREATMENT OF DISC DEGENERATIVE DISEASE | SCHUBERG, LAURA J | 1631 | §103Other | Final Rejection | — | Pending | Mar 24, 2022 |
| 17595112 | FIBROBLAST GENERATED PATIENT-SPECIFIC VACCINES | CHASE, CAROL ANN | 1646 | §102§103§112 | Non-Final OA | 43d overdue | Pending | Nov 09, 2021 |
| 17310051 | FIBROBLASTS AND MICROVESICLES THEREOF FOR REDUCTION OF TOXICITY ASSOCIATED WITH CANCER IMMUNOTHERAPY | DHAR, MATASHA | 1632 | §103§112 | Final Rejection | 86d overdue | Pending | Jul 13, 2021 |
| 17310007 | FIBROBLAST REGENERATIVE CELLS | TRAN, KHOA NHAT | 1632 | §103§112 | Non-Final OA | 25d overdue | Pending | Jul 09, 2021 |
| 17309207 | REGENERATIVE ABSCOPAL EFFECTS | RIGA, MICHAEL ANGELO | 1634 | §103§112 | Non-Final OA | 14d | Pending | May 26, 2021 |
| 17309178 | TREATMENT OF CEREBRAL HYPOXIA INCLUDING STROKE, CHRONIC TRAUMATIC ENCEPHALOPATHY, AND TRAUMATIC BRAIN INJURY | XU, QING | 1656 | §103§112Other | Non-Final OA | 3d overdue | Pending | May 03, 2021 |
| 17271529 | CHIMERIC ANTIGEN RECEPTOR FIBROBLAST CELLS FOR TREATMENT OF CANCER | LEVIN, JOEL D | 1633 | §102 | Final Rejection | — | Pending | Feb 25, 2021 |
| 17251587 | USE OF FIBROBLASTS AND/OR MODIFIED FIBROBLASTS FOR THREE DIMENSIONAL TISSUE PRINTING | REGLAS, GILLIAN CHELSEA | 1632 | §103§112 | Non-Final OA | 27d | Pending | Dec 11, 2020 |
| 17052859 | PAIN-REDUCING EFFECTS OF FIBROBLASTS AND TREATMENT OF PAIN | TRAN, KHOA NHAT | 1632 | §103§112 | Final Rejection | 73d overdue | Pending | Nov 04, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial